KCTD10, a member of the potassium channel tetramerization domain (KCTD) family, is implicated in neuropsychiatric disorders and functions as a substrate recognition component within the RING-type ubiquitin ligase complex. A rare de novo variant of KCTD10, p.C124W, was identified in schizophrenia cases, yet its underlying pathogenesis remains unexplored. Here, we demonstrate that heterozygous KCTD10 C124W mice display pronounced synaptic abnormalities and exhibit schizophrenia-like behaviors. Mechanistically, we reveal that KCTD10 undergoes liquid-liquid phase separation (LLPS), a process orchestrated by its intrinsically disordered region (IDR). p.C124W mutation disrupts this LLPS capability, leading to diminished degradation of RHOB and subsequent excessive accumulation in the postsynaptic density fractions. Notably, neither IDR deletion nor p.C124W mutation in KCTD10 mitigates the synaptic abnormalities caused by Kctd10 deficiency. Thus, our findings implicate that LLPS may be associated with the pathogenesis of KCTD10-associated brain disorders and highlight the potential of targeting RHOB as a therapeutic strategy for diseases linked to mutations in KCTD10 or RHOB.
KCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation.
KCTD10 p.C124W 变异通过减弱 LLPS 介导的突触形成而导致精神分裂症
阅读:4
作者:Mu Chenjun, Liu Pan, Liu Liang, Wang Yaqing, Liu Kefu, Li Xiangyu, Li Guozhong, Cheng Jianbo, Bu Mengyao, Chen Han, Tang Manpei, Yao Yuanhang, Guan Jun, Ma Tiantian, Zhou Zhengrong, Wu Qingfeng, Li Jiada, Guo Hui, Xia Kun, Hu Zhengmao, Peng Xiaoqing, Lang Bing, Li Faxiang, Chen Xiao-Wei, Xu Zhiheng, Yuan Ling
| 期刊: | Proceedings of the National Academy of Sciences of the United States of America | 影响因子: | 9.100 |
| 时间: | 2024 | 起止号: | 2024 Nov 26; 121(48):e2400464121 |
| doi: | 10.1073/pnas.2400464121 | 研究方向: | 神经科学 |
| 疾病类型: | 精神分裂症 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
